4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-009038
CEO and Chairman sold 22,240 shares at an average $31.24 ($694,778)
- CEO and Chairman acquired 22,240 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBINS CHAD M CEO and Chairman | 2020-02-11 | Option exercise | +11,120 | $0.33 | $3,670 | 1,889,300 | D: show line 1 in the form |
| ROBINS CHAD M CEO and Chairman | 2020-02-11 | Sale | −11,120 | $31.18 | $346,722 | 1,878,180 | D: show line 2 in the form |
| ROBINS CHAD M CEO and Chairman | 2020-02-12 | Option exercise | +11,120 | $0.33 | $3,670 | 1,889,300 | D: show line 3 in the form |
| ROBINS CHAD M CEO and Chairman | 2020-02-12 | Sale | −11,120 | $31.30 | $348,056 | 1,878,180 | D: show line 4 in the form |
| Open-market sales · 22,240 sh · avg $31.24 · $694,778 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| ROBINS CHAD M CEO and Chairman | 2020-02-11 | Option exercise · Stock Option (Right to Buy) | −11,120 | 735,200 | D: show line 5 in the form | |||||
| ROBINS CHAD M CEO and Chairman | 2020-02-12 | Option exercise · Stock Option (Right to Buy) | −11,120 | 724,000 | D: show line 6 in the form |
Loading xslF345X03/doc4.xml…